Published in Hum Mol Genet on January 15, 2001
Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes Dev (2006) 3.18
Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell (2011) 2.73
hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay. Mol Cell Biol (2006) 2.69
Nonsense-mediated mRNA decay factors act in concert to regulate common mRNA targets. RNA (2005) 2.59
Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat Genet (2007) 2.35
Nonsense-mediated mRNA decay (NMD) mechanisms. Nat Struct Mol Biol (2009) 2.31
An unappreciated role for RNA surveillance. Genome Biol (2004) 2.28
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev (2008) 2.26
An alternative branch of the nonsense-mediated decay pathway. EMBO J (2007) 2.01
SMG-5, required for C.elegans nonsense-mediated mRNA decay, associates with SMG-2 and protein phosphatase 2A. EMBO J (2003) 1.83
Mechanistic insights and identification of two novel factors in the C. elegans NMD pathway. Genes Dev (2007) 1.74
Preventing dangerous nonsense: selection for robustness to transcriptional error in human genes. PLoS Genet (2011) 1.63
Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes. Nat Rev Mol Cell Biol (2015) 1.61
Regulation of nonsense-mediated mRNA decay: implications for physiology and disease. Biochim Biophys Acta (2013) 1.59
Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay. Proc Natl Acad Sci U S A (2010) 1.59
PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nat Neurosci (2012) 1.58
Nonsense-mediated mRNA decay (NMD) in animal embryogenesis: to die or not to die, that is the question. Curr Opin Genet Dev (2011) 1.52
RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD. Mol Cell (2011) 1.50
A GFP-based reporter system to monitor nonsense-mediated mRNA decay. Nucleic Acids Res (2005) 1.49
Nonsense-mediated mRNA decay effectors are essential for zebrafish embryonic development and survival. Mol Cell Biol (2009) 1.44
Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis. Mol Cancer Res (2010) 1.44
Unusual bipartite mode of interaction between the nonsense-mediated decay factors, UPF1 and UPF2. EMBO J (2009) 1.44
Global analyses of UPF1 binding and function reveal expanded scope of nonsense-mediated mRNA decay. Genome Res (2013) 1.39
Functions of the nonsense-mediated mRNA decay pathway in Drosophila development. PLoS Genet (2006) 1.36
Translation-dependent displacement of UPF1 from coding sequences causes its enrichment in 3' UTRs. Nat Struct Mol Biol (2013) 1.26
Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet (2014) 1.23
The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryos. Mol Cell Biol (2003) 1.21
Nonsense-mediated decay of alternative precursor mRNA splicing variants is a major determinant of the Arabidopsis steady state transcriptome. Plant Cell (2013) 1.19
Caenorhabditis elegans SMG-2 selectively marks mRNAs containing premature translation termination codons. Mol Cell Biol (2007) 1.18
Upf1, an RNA helicase required for nonsense-mediated mRNA decay, modulates the transcriptional response to oxidative stress in fission yeast. Mol Cell Biol (2006) 1.18
A UPF3-mediated regulatory switch that maintains RNA surveillance. Nat Struct Mol Biol (2009) 1.16
Nonsense-mediated mRNA decay in yeast does not require PAB1 or a poly(A) tail. Mol Cell (2008) 1.14
Noisy splicing, more than expression regulation, explains why some exons are subject to nonsense-mediated mRNA decay. BMC Biol (2009) 1.11
Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression. PLoS One (2013) 1.11
Crystal structure of the UPF2-interacting domain of nonsense-mediated mRNA decay factor UPF1. RNA (2006) 1.11
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res (2013) 1.09
Aberrant growth and lethality of Arabidopsis deficient in nonsense-mediated RNA decay factors is caused by autoimmune-like response. Nucleic Acids Res (2012) 1.08
Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdiscip Rev RNA (2011) 1.08
Expression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay. BMC Genomics (2010) 1.07
Splicing-dependent NMD does not require the EJC in Schizosaccharomyces pombe. EMBO J (2010) 1.06
Perturbation of thymocyte development in nonsense-mediated decay (NMD)-deficient mice. Proc Natl Acad Sci U S A (2011) 1.03
Dhx34 and Nbas function in the NMD pathway and are required for embryonic development in zebrafish. Nucleic Acids Res (2011) 1.00
Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res (2016) 0.99
Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol Psychiatry (2011) 0.99
Nonsense-Mediated mRNA Decay: Degradation of Defective Transcripts Is Only Part of the Story. Annu Rev Genet (2015) 0.98
Gene expression networks: competing mRNA decay pathways in mammalian cells. Biochem Soc Trans (2009) 0.96
Drosophila Upf1 and Upf2 loss of function inhibits cell growth and causes animal death in a Upf3-independent manner. RNA (2011) 0.96
Gene set coregulated by the Saccharomyces cerevisiae nonsense-mediated mRNA decay pathway. Eukaryot Cell (2005) 0.95
Nonsense-mediated mRNA decay: inter-individual variability and human disease. Neurosci Biobehav Rev (2013) 0.94
UPF2 is a critical regulator of liver development, function and regeneration. PLoS One (2010) 0.93
Human UPF1 participates in small RNA-induced mRNA downregulation. Mol Cell Biol (2009) 0.93
Upf1/Upf2 regulation of 3' untranslated region splice variants of AUF1 links nonsense-mediated and A+U-rich element-mediated mRNA decay. Mol Cell Biol (2006) 0.93
Identification of delta helicase as the bovine homolog of HUPF1: demonstration of an interaction with the third subunit of DNA polymerase delta. Nucleic Acids Res (2002) 0.91
Smg6/Est1 licenses embryonic stem cell differentiation via nonsense-mediated mRNA decay. EMBO J (2015) 0.91
Human Upf1 is a highly processive RNA helicase and translocase with RNP remodelling activities. Nat Commun (2015) 0.90
A Hox gene mutation that triggers nonsense-mediated RNA decay and affects alternative splicing during Drosophila development. Nucleic Acids Res (2003) 0.90
Is there a classical nonsense-mediated decay pathway in trypanosomes? PLoS One (2011) 0.88
Regulation of natural mRNAs by the nonsense-mediated mRNA decay pathway. Eukaryot Cell (2014) 0.88
Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity. Proc Natl Acad Sci U S A (2013) 0.87
A novel role for hSMG-1 in stress granule formation. Mol Cell Biol (2011) 0.86
Under the Tucson sun: a meeting in the desert on mRNA decay. RNA (2004) 0.86
Cross talk between immunoglobulin heavy-chain transcription and RNA surveillance during B cell development. Mol Cell Biol (2011) 0.86
In vivo determination of direct targets of the nonsense-mediated decay pathway in Drosophila. G3 (Bethesda) (2014) 0.86
Nonsense-mediated mRNA decay and development: shoot the messenger to survive? Biochem Soc Trans (2010) 0.83
Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc Natl Acad Sci U S A (2015) 0.82
Caspases shutdown nonsense-mediated mRNA decay during apoptosis. Cell Death Differ (2015) 0.82
Eukaryotic initiation factor 4G suppresses nonsense-mediated mRNA decay by two genetically separable mechanisms. PLoS One (2014) 0.82
Functional characterization of Upf1 targets in Schizosaccharomyces pombe. RNA Biol (2013) 0.81
Degradation of Gadd45 mRNA by nonsense-mediated decay is essential for viability. Elife (2016) 0.81
Autoimmunity as a result of escape from RNA surveillance. J Immunol (2006) 0.81
Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5. Biomed Res Int (2013) 0.80
Smg1 haploinsufficiency predisposes to tumor formation and inflammation. Proc Natl Acad Sci U S A (2012) 0.80
Physiological and pathophysiological role of nonsense-mediated mRNA decay. Pflugers Arch (2016) 0.80
Mutations in SMG9, Encoding an Essential Component of Nonsense-Mediated Decay Machinery, Cause a Multiple Congenital Anomaly Syndrome in Humans and Mice. Am J Hum Genet (2016) 0.79
Chromatoid Body Protein TDRD6 Supports Long 3' UTR Triggered Nonsense Mediated mRNA Decay. PLoS Genet (2016) 0.78
TRPC1 transcript variants, inefficient nonsense-mediated decay and low up-frameshift-1 in vascular smooth muscle cells. BMC Mol Biol (2011) 0.78
Recent transcriptome-wide mapping of UPF1 binding sites reveals evidence for its recruitment to mRNA before translation. Translation (Austin) (2013) 0.77
Nonsense-Mediated RNA Decay Influences Human Embryonic Stem Cell Fate. Stem Cell Reports (2016) 0.77
Evolutionarily conserved autoregulation of alternative pre-mRNA splicing by ribosomal protein L10a. Nucleic Acids Res (2016) 0.77
Control of gene expression through the nonsense-mediated RNA decay pathway. Cell Biosci (2017) 0.75
Fluorescence Amplification Method for Forward Genetic Discovery of Factors in Human mRNA Degradation. Mol Cell (2016) 0.75
RNA Decay, Evolution, and the Testis. RNA Biol (2016) 0.75
MicroRNA 433 regulates nonsense-mediated mRNA decay by targeting SMG5 mRNA. BMC Mol Biol (2016) 0.75
A whole-genome analysis of premature termination codons. Genomics (2011) 0.75
High-resolution profiling of NMD targets in yeast reveals translational fidelity as a basis for substrate selection. RNA (2017) 0.75
In Silico Analysis of the Structural and Biochemical Features of the NMD Factor UPF1 in Ustilago maydis. PLoS One (2016) 0.75
A GC-rich sequence feature in the 3' UTR directs UPF1-dependent mRNA decay in mammalian cells. Genome Res (2016) 0.75
DNA substrate recognition and processing by the full-length human UPF1 helicase. Nucleic Acids Res (2017) 0.75
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev (1998) 12.48
Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet (1996) 7.84
Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet (1999) 6.90
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene (2006) 5.38
MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer (2006) 5.37
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet (1995) 3.74
The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev (1998) 3.71
Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet (1997) 2.98
A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest (1994) 2.98
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet (1999) 2.90
A mutated human homologue to yeast Upf1 protein has a dominant-negative effect on the decay of nonsense-containing mRNAs in mammalian cells. Proc Natl Acad Sci U S A (1998) 2.87
A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat Biotechnol (2001) 2.82
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A (1999) 2.80
When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell (2001) 2.55
Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med (2010) 2.55
The molecular genetics of Marfan syndrome and related disorders. J Med Genet (2006) 2.45
A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med (1994) 2.29
Mammalian orthologues of a yeast regulator of nonsense transcript stability. Proc Natl Acad Sci U S A (1996) 2.24
Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res (2001) 2.22
MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer (2007) 2.19
Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg (1999) 2.08
Novel Upf2p orthologues suggest a functional link between translation initiation and nonsense surveillance complexes. Mol Cell Biol (2000) 2.07
Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet (2001) 2.07
Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end. Genomics (1993) 2.05
Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet (1995) 2.01
Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet (2001) 1.75
Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat Genet (1993) 1.74
Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation (2001) 1.69
Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood (1996) 1.57
A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet (1993) 1.53
Adult B-cell repertoire is biased toward two heavy-chain variable-region genes that rearrange frequently in fetal pre-B cells. Proc Natl Acad Sci U S A (1987) 1.46
Regulation of left-right patterning in mice by growth/differentiation factor-1. Nat Genet (2000) 1.43
Mice lacking ornithine-delta-aminotransferase have paradoxical neonatal hypoornithinaemia and retinal degeneration. Nat Genet (1995) 1.39
Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am J Hum Genet (1991) 1.35
Nonsense mutations and diminished mRNA levels. Nat Genet (1993) 1.34
Neuroradiologic manifestations of Loeys-Dietz syndrome type 1. AJNR Am J Neuroradiol (2009) 1.33
Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet (1996) 1.31
Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol (1996) 1.27
Extracellular microfibrils in development and disease. Cell Mol Life Sci (2007) 1.21
A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A (1997) 1.20
Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest (1994) 1.19
Mutations in KRIT1 in familial cerebral cavernous malformations. Neurosurgery (2000) 1.12
Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. Hum Mol Genet (1993) 1.12
Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence. Hum Mol Genet (1997) 1.12
Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet (1997) 1.10
Growth retardation and neonatal lethality in mice with a homozygous deletion in the C-terminal domain of RNA polymerase II. Mol Gen Genet (1999) 1.08
Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet (1998) 1.07
Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest (1995) 1.07
Characterization of GDF-10 expression patterns and null mice. Dev Biol (1999) 1.01
Revised genomic organization of FBN1 and significance for regulated gene expression. Genomics (1999) 1.00
Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome. Br J Pharmacol (2007) 0.99
Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J Clin Invest (1996) 0.98
Craniofacial abnormalities resulting from targeted disruption of the murine Sim2 gene. Dev Dyn (2002) 0.97
Nonsense mutations and altered splice-site selection. Am J Hum Genet (1997) 0.97
Enzymatic mutation detection (EMD) of novel mutations (R565X and R1523X) in the FBN1 gene of patients with Marfan syndrome using T4 endonuclease VII. Hum Mutat (2000) 0.96
The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome. Vet Pathol (2010) 0.94
Anomalous lacrimal ductule: case report and review. J Pediatr Ophthalmol Strabismus (1995) 0.91
Marfan syndrome as a paradigm for transcript-targeted preimplantation diagnosis of heterozygous mutations. Nat Med (1995) 0.90
Cloning of the murine Krit1 cDNA reveals novel mammalian 5' coding exons. Genomics (2000) 0.89
Characterization of microsatellite markers flanking FBN1: utility in the diagnostic evaluation for Marfan syndrome. Am J Med Genet (2001) 0.88
Substitution of a cysteine residue in a non-calcium binding, EGF-like domain of fibrillin segregates with the Marfan syndrome in a large kindred. Hum Mol Genet (1994) 0.87
GenTAC registry report: gender differences among individuals with genetically triggered thoracic aortic aneurysm and dissection. Am J Med Genet A (2013) 0.85
Restoration of open reading frame resulting from skipping of an exon with an internal deletion in the COL7A1 gene. Lab Invest (1998) 0.84
Targeted disruption of Gnas in embryonic stem cells. Endocrinology (1997) 0.82
Orbital lymphomas and pseudolymphomas: a clinicopathologic study of eleven cases. Am J Clin Pathol (1977) 0.82
Nonstop treatment of cystic fibrosis. Nat Med (1996) 0.82
The Marfan syndrome and the cardiovascular surgeon. Eur J Cardiothorac Surg (1996) 0.80
Molecular biology--to the heart of the matter. N Engl J Med (1994) 0.80
Generation of antibody diversity before and after immunization. Ann N Y Acad Sci (1988) 0.79
Preimplantation genetic diagnosis of human embryos for Marfan's syndrome. J Assist Reprod Genet (1998) 0.78
Fibrillin (FBN1) mutations in Marfan syndrome. Hum Mutat (1992) 0.78
Troubleshooting in gene splicing by overlap extension: a step-wise method. Mol Biotechnol (1999) 0.77
CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb. Exp Hematol (1998) 0.77
Osteogenic sarcoma and phthisis bulbi: a case report. Ophthal Plast Reconstr Surg (2000) 0.75
Interaction of ribonuclease T1 with DNA, mononucleotides and oligonucleotides. Biochem Biophys Res Commun (1982) 0.75
Evaluation of inhA gene and catalase-peroxidase gene among isoniazid-sensitive and resistant Mycobacterium tuberculosis isolates. Mol Cell Probes (1996) 0.75
Molecular biology of Marfan syndrome. J Vasc Surg (1992) 0.75
Meaning of "medically fit to travel". Voyageur Travel Insurance. CMAJ (1994) 0.75
Alterations of yeast artificial chromosome transgenic sequences in stretched embryonic stem-cell chromatin visualized by fluorescence in situ hybridization. Cytogenet Cell Genet (1996) 0.75
Acute emphysematous cholecystitis due to Clostridium perfringens. Ala J Med Sci (1978) 0.75